139 related articles for article (PubMed ID: 21945313)
1. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
3. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
Schwentner L; Van Ewijk R; Kurzeder C; Hoffmann I; König J; Kreienberg R; Blettner M; Wöckel A
Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
[TBL] [Abstract][Full Text] [Related]
4. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
[TBL] [Abstract][Full Text] [Related]
5. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
6. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy.
Abdalla I; Thisted RA; Heimann R
Cancer J; 2000; 6(4):266-72. PubMed ID: 11038147
[TBL] [Abstract][Full Text] [Related]
7. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
Wöckel A; Kurzeder C; Geyer V; Novasphenny I; Wolters R; Wischnewsky M; Kreienberg R; Varga D
Breast; 2010 Apr; 19(2):120-7. PubMed ID: 20117932
[TBL] [Abstract][Full Text] [Related]
8. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.
Wöckel A; Varga D; Atassi Z; Kurzeder C; Wolters R; Wischnewsky M; Wulff C; Kreienberg R
Onkologie; 2010; 33(1-2):21-8. PubMed ID: 20164658
[TBL] [Abstract][Full Text] [Related]
9. Synchronous, bilateral breast cancer: prognostic value and incidence.
Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH
Breast; 2003 Apr; 12(2):83-8. PubMed ID: 14659335
[TBL] [Abstract][Full Text] [Related]
10. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
Varga D; Wischnewsky M; Atassi Z; Wolters R; Geyer V; Strunz K; Kreienberg R; Woeckel A
Oncology; 2010; 78(3-4):189-95. PubMed ID: 20414007
[TBL] [Abstract][Full Text] [Related]
11. pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
Reinisch M; Huober J; von Minckwitz G; Blohmer JU; Denkert C; Hanusch C; Jackisch C; Kümmel S; Schneeweiss A; Rhiem K; Lederer B; Untch M; Nekljudova V V; Loibl S
Breast; 2017 Apr; 32():73-78. PubMed ID: 28063331
[TBL] [Abstract][Full Text] [Related]
12. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
13. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
14. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics.
Kheirelseid EA; Jumustafa H; Miller N; Curran C; Sweeney K; Malone C; McLaughlin R; Newell J; Kerin MJ
Breast Cancer Res Treat; 2011 Feb; 126(1):131-40. PubMed ID: 20665107
[TBL] [Abstract][Full Text] [Related]
15. Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients.
Van Ewijk R; Wöckel A; Gundelach T; Hancke K; Janni W; Singer S; Kreienberg R; Blettner M; Schwentner L
Arch Gynecol Obstet; 2015 Mar; 291(3):631-40. PubMed ID: 25178186
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Beinart G; Gonzalez-Angulo AM; Broglio K; Mejia J; Ruggeri A; Mininberg E; Hortobagyi GN; Valero V
Clin Breast Cancer; 2007 Dec; 7(11):867-74. PubMed ID: 18269777
[TBL] [Abstract][Full Text] [Related]
17. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018).
Pan B; Xu Y; Zhou YD; Yao R; Wu HW; Zhu QL; Wang CJ; Mao F; Lin Y; Shen SJ; Sun Q
Cancer Med; 2019 Jun; 8(6):2908-2918. PubMed ID: 31038845
[TBL] [Abstract][Full Text] [Related]
18. Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients.
Wolters R; Ebner F; Janni W; Novopashenny I; Wöckel A; Kreienberg R; Wischnewsky M; Schwentner L;
Arch Gynecol Obstet; 2016 Aug; 294(2):377-84. PubMed ID: 26894302
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
20. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.
Wöckel A; Wolters R; Wiegel T; Novopashenny I; Janni W; Kreienberg R; Wischnewsky M; Schwentner L;
Ann Oncol; 2014 Mar; 25(3):628-632. PubMed ID: 24515935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]